Costello Asset Management’s AbbVie ABBV Stock Holding History

Costello Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Buy	1,268 +1	+0.1%	+$222	0.1%	92
2025 Q4	$290K	Hold	1,267	–	–	0.1%	93
2025 Q3	$293K	Buy	1,267 +1	+0.1%	+$204	0.1%	92
2025 Q2	$235K	Buy	1,266 +29	+2%	+$5.39K	0.09%	100
2025 Q1	$259K	Buy	+1,237	New	+$240K	0.11%	92
2023 Q4	–	Sell	-60	Closed	-$8.94K	–	181
2023 Q3	$8.94K	Hold	60	–	–	0.01%	148
2023 Q2	$8.08K	Sell	60 -40	-40%	-$5.87K	0.01%	147
2023 Q1	$15.9K	Hold	100	–	–	0.02%	130
2022 Q4	$16.2K	Hold	100	–	–	0.01%	133
2022 Q3	$13K	Hold	100	–	–	0.01%	140
2022 Q2	$15K	Hold	100	–	–	0.01%	145
2022 Q1	$16K	Buy	100 +65	+186%	+$9.44K	0.01%	155
2021 Q4	$5K	Sell	35 -176	-83%	-$20.8K	﹤0.01%	192
2021 Q3	$23K	Buy	211 +30	+17%	+$3.43K	0.01%	144
2021 Q2	$20K	Buy	181 +1	+0.6%	+$113	0.01%	145
2021 Q1	$20K	Buy	180 +26	+17%	+$2.78K	0.01%	154
2020 Q4	$16K	Buy	154 +2	+1%	+$192	0.01%	157
2020 Q3	$13K	Buy	152 +2	+1%	+$188	0.01%	145
2020 Q2	$15K	Buy	+150	New	+$13.2K	0.01%	135

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Costello Asset Management's ABBV Position: Q1 2026 in Review

Costello Asset Management increased its AbbVie (ABBV) stake by 0.08% in Q1 2026, buying an estimated $222 and bringing the position to 1,268 shares worth $276K. The position accounts for 0.1% of the portfolio, ranked #92.

Costello Asset Management first reported a position in ABBV in Q2 2020 and has held it in 19 quarters since. The position peaked at $293K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Costello Asset Management held 1,268 shares of AbbVie worth $276K as of Q1 2026.
Costello Asset Management bought 1 AbbVie share in Q1 2026, an estimated $222.
AbbVie made up 0.1% of Costello Asset Management's portfolio in Q1 2026, its #92 holding.
Costello Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 19 quarters since.
Costello Asset Management's AbbVie position peaked at $293K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Costello Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.